Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Si

/PRNewswire/ -- Sirnaomics Ltd. (the "Company"; stock code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical...

Related Keywords

Suzhou , Jiangsu , China , Chinese , Michael Molyneaux , Patrick Lu , Prnewswire Sirnaomics Ltd , Drug Administration , Chinese National Medical Products Administration , Group Or Sirnaomics , Squamous Cell Carcinoma , Basal Cell Carcinoma , Executive Director , Chief Executive Officer , Chief Medical Officer , Orphan Drug Designation ,